Announcements Trials

Browse Landscape

Phase

Phase 2 25 Phase 3 9 Phase 1 7 Phase 1/2 6 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 4 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Temozolomide 2 Paclitaxel 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Carboplatin 2 temsirolimus 1 sugemalimab 1 semaglutide 1 sacituzumab govitecan 1 prednylidene 1 pirtobrutinib 1 paricalcitol 1 pamiparib 1 olaparib 1 mirdametinib 1 gadobutrol 1 fludarabine phosphate 1 fludarabine 1 erdafitinib 1 enfortumab vedotin 1 dupilumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 daratumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × olaparib × 30 days × Clear all

NCT04614909 2026-05-14

Study of Pamiparib in Newly Diagnosed and rGBM

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡